Clinical Trials Browser

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Neuroma, Acoustic, Pinealoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

NCT04740190 2025-06-11

TAC-GReD

Phase 2 Completed

33 enrolled

CNS

Glioblastoma, Glioma

NCT04051606 2025-06-05

Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma

Phase 2 Completed

14 enrolled

CNS

Glioblastoma

NCT03452930 2025-06-04

Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma

Phase 1 Completed

5 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT03834740 2025-05-30

A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection

Phase EARLY_PHASE1 Completed

27 enrolled 17 charts

CNS

Brain Neoplasms, Glioblastoma, Glioma

NCT03477110 2025-05-15

Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma

Phase EARLY_PHASE1 Completed

30 enrolled

CNS

Glioblastoma

NCT03665545 2025-05-13

IMA950-106

Phase 1/2 Completed

18 enrolled

CNS

Glioblastoma

NCT02186509 2025-04-30

Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas

Phase 1 Completed

17 enrolled 11 charts

CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT02715609 2025-04-10

Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Phase 1/2 Completed

35 enrolled 16 charts

CNS

Glioblastoma

NCT05759195 2025-03-13

RegoRec

Phase NA Completed

53 enrolled

CNS

Glioblastoma

NCT05772767 2025-03-13

RF2019-1236878

Phase NA Completed

100 enrolled

CNS

Glioblastoma, Glioma

NCT03344250 2025-03-06

Phase I EGFR BATs in Newly Diagnosed Glioblastoma

Phase 1 Completed

16 enrolled

CNS

Glioblastoma

NCT05131815 2025-02-26

The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors

Phase NA Completed

8 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidOther hematologic neoplasmPlasma cellSarcomaThoracic

Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Gastrointestinal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Hodgkin Disease, Leukemia, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Motor Activity, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Skin Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms

NCT01894061 2025-02-17

NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma

Phase 2 Completed

25 enrolled 16 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Clinical Trials

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

UC-GlioFET

Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma

LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients

Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)

Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma

GEINOCANN

Feasibility of Individualized Therapy for Recurrent Glioblastoma

Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues

INDYGO

REGOMA-2

GLIOPLAK

Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

SupraGlio-AI

EVA DOPA

FET-TREAT

DOSINDYGO

Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

ASP8374 + Cemiplimab in Recurrent Glioma

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

CBT-I in PBT

GlioMET

Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

PROMESSE

RESECT

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Chlorpromazine and Standard of Care in Glioblastoma

PriCoTTF

Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma

HUMC 1612: Optune NovoTTF-200A System

ONCOhabitats

ALBATROSS

BIOhabitats

18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy

Temozolomide Chronotherapy for High Grade Glioma

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

TAC-GReD

Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma

Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma

A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection

Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma

IMA950-106

Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas

Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

RegoRec

RF2019-1236878

Phase I EGFR BATs in Newly Diagnosed Glioblastoma

The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors

NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma